Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: An in vitro evaluation

Journal of Drug Targeting

Volumn 19, Issue 4, 2011, Pages 239-250

  Khan, Wahid ^a   Kumar, Neeraj ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

albumin microspheres; parenteral delivery; Paromomycin; spray drying; thermal stabilization

Indexed keywords

ALBUMIN MICROSPHERE; BOVINE SERUM ALBUMIN; PAROMOMYCIN;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTACT ANGLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INTERACTION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; EVALUATION; HEATING; IN VITRO STUDY; LABELING INDEX; MACROPHAGE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPRAY DRYING; THERMOGRAVIMETRY; THERMOSTABILITY; VISCERAL LEISHMANIASIS;

ALBUMINS; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MICROSPHERES; PAROMOMYCIN;

EID: 79952994973     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.492524     Document Type: Article

References (40)

1. Agrawal S, Rai M, Sundar S. (2005). Management of visceral leishmaniasis: Indian perspective. J Postgrad Med, 51 Suppl 1, S53-S57.
2. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release, 79, 29-40. (Pubitemid 34164159)
3. Akhavein N, Oettinger CW, Gayakwad SG, Addo RT, Bejugam NK, Bauer JD, Do D, Pollock SH, D'Souza MJ. (2008). Treatment of adjuvant arthritis using microencapsulated antisense NF-fcB oligonucleotides. J Microencapsul, 26, 223-234.
4. Babajimopoulos M, Mikolajcik EM. (1978). Infuence of heat treatment on antigenicity of bovine serum albumin in milk and model systems. J Dairy Sci, 61, 1380-1383.
5. Bian H, Li M, Yu Q, Chen Z, Tian J, Liang H. (2006). Study of the interaction of indirubin with bovine serum albumin. Chem Pharm Bull, 54, 1239-1243. (Pubitemid 44351513)
6. Briones E, Colino CI, Lanao JM. (2008). Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release, 125, 210-227.
7. Burgess DJ, Davis SS, Tomlinson E. (1987). Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. Int J Pharm 39, 129-136. (Pubitemid 17123100)
8. Chellat F, Merhi Y Moreau A, Yahia L. (2005). Terapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials, 26, 7260-7275. (Pubitemid 41133578)
9. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profles. Eur J Pharm Sci, 13, 123-133.
10. Dandagi PM, Mastiholimath VS, Patil MB, Gupta MK. (2006). Biodegradable microparticulate system of captopril. Int J Pharm, 307, 83-88. (Pubitemid 41773255)
11. Date AA, Joshi MD, Patravale VB. (2007). Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev, 59, 505-521. (Pubitemid 47259228)
12. Davidson RN, den Boer M, Ritmeijer K. (2009). Paromomycin. Trans R Soc Trop Med Hyg, 103, 653-660.
13. Dea-Ayuela MA, Rama-Iñiguez S, Sánchez-Brunete JA, Torrado JJ, Alunda JM, Bolás-Fernández F. (2004). Anti-leishmanial activity of a new formulation of amphotericin B. Trop Med Int Health, 9, 981-990. (Pubitemid 39278999)
14. Gibson SG. (2001). How to optimize your spray dryer's performance. Powder Bulk Eng, 15, 31-41.
15. Grinberg O, Hayun M, Sredni B, Gedanken A. (2007). Characterization and activity of sonochemically-prepared BSA microspheres containing Taxol-an anticancer drug. Ultrason Sonochem, 14, 661-666. (Pubitemid 46656474)
16. Gupta PK, Hung CT. (1989a). Albumin microspheres. I: Physico-chemical characteristics. J Microencapsul, 6, 427-462.
17. Gupta PK, Hung CT. (1989b). Albumin microspheres. II: Applications in drug delivery. J Microencapsul, 6, 463-472. (Pubitemid 19278415)
18. Gupta S, Dube A, Vyas SP. (2007). Antileishmanial efcacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target, 15, 437-444. (Pubitemid 47073059)
19. Gupta S, Vyas SP. (2007). Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target, 15, 206-217. (Pubitemid 46562633)
20. Haswani DK, Nettey H, Oettinger C, D'Souza MJ. (2006). Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsul, 23, 875-886. (Pubitemid 46332099)
21. Li FQ, Hu JH, Lu B, Yao H, Zhang WG. (2001). Ciprofoxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitro. J Microencapsul, 18, 825-829. (Pubitemid 32998327)
22. Luftensteiner CP, Schwendenwein I, Paul B, Eichler HG, Viernstein H. (1999). Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats. J Control Release, 57, 35-44. (Pubitemid 29005071)
23. Nan A, Croft SL, Yardley V Ghandehari H. (2004). Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis. J Control Release, 94, 115-127. (Pubitemid 37542382)
24. Nettey H, Haswani D, Oettinger CW, D'Souza MJ. (2006). Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. J Microencapsul, 23, 632-642. (Pubitemid 44803856)
25. Paul M, Durand R, Boulard Y Fusaï T, Fernandez C, Rivollet D, Deniau M, Astier A. (1998). Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice. J Drug Target, 5, 481-490. (Pubitemid 28499682)
26. Peng ZG, Hidajat K, Uddin KMS. (2004). Conformational change of adsorbed and desorbed bovine serum albumin on nano-sized magnetic particles. Colloids Surf B, 33 15-21. (Pubitemid 38050059)
27. Prior S, Gander B, Blarer N, Merkle HP, Subirá ML, Irache JM, Gamazo C (2002). In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci, 15, 197-207. (Pubitemid 34155382)
28. Romero EL, Morilla MJ. (2008). Drug delivery systems against leishmaniasis? Still an open question. Expert Opin Drug Deliv, 5, 805-823.
29. Sánchez-Brunete JA, Dea MA, Rama S, Bolás F, Alunda JM, Torrado-Santiago S, Torrado JJ. (2005). Infuence of the vehicle on the properties and efcacy of microparticles containing amphotericin B. J Drug Target, 13, 225-233. (Pubitemid 41086287)
30. Schäfer V von Briesen H, Rübsamen-Waigmann H, Stefan AM, Royer C, Kreuter J. (1994). Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. J Microencapsul, 11, 261-269. (Pubitemid 24148435)
31. Schefel U, Rhodes BA, Natarajan TK, Wagner HN Jr. (1972). Albumin microspheres for study of the reticuloendothelial system. J Nucl Med, 13, 498-503.
32. Singh RK, Pandey HP, Sundar S. (2006). Visceral leishmaniasis (kala-azar): challenges ahead. Indian J Med Res, 123, 331-344. (Pubitemid 43905573)
33. Sundar S, Jha TK, Takur CP, Sinha PK, Bhattacharya SK. (2007). Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med, 356, 2571-2581. (Pubitemid 46961002)
34. Tabata Y Ikada Y (1988). Efect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 9, 356-362.
35. Takur CP. (2008). Tetany in kala azar patients treated with paromomycin. Indian J Med Res, 127, 489-493.
36. Torche AM, Le Corre P, Albina E, Jestin A, Le Verge R. (2000). PLGA microspheres phagocytosis by pig alveolar macrophages: infuence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature. J Drug Target, 7, 343-354. (Pubitemid 30137957)
37. Torrado JJ, Illum L, Davis SS. (1989). Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. Int J Pharm 51, 85-93. (Pubitemid 19087837)
38. Venier-Julienne MC, Vouldoukis I, Monjour L, Benoit JP. (1995). In vitro study of the anti-leishmanial activity of biodegradable nanoparticles. J Drug Target, 3, 23-29.
39. Verma RK, Garg S. (2005). Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J Pharm Biomed Anal, 38, 633-644. (Pubitemid 40835561)
40. Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 56, 1257-1272. (Pubitemid 38510473)